InvestmentPitch Media Video Discusses FSD Pharma's Submission of an Investigational New Drug or 'IND' Application with the U.S. Food and Drug Administration and Health Canada for Treatment of a Yet-To
yahoo.com
news
2022-06-01 10:00:00

InvestmentPitch Media and FSD Pharma

VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) -- FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FSE:0K9A), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, has submitted an Investigational New Drug or 'IND' application with the U.S. Food and Drug Administration and Health Canada. The IND application details a planned phase 2 clinical trial of FSD-PEA for the treatment of a yet-to-be-disclosed inflammatory disorder.
